Risk Factors for Major Bleeding in Rivaroxaban Users With Atrial Fibrillation

J Am Coll Cardiol. 2016 Sep 6;68(10):1144-6. doi: 10.1016/j.jacc.2016.06.028.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atrial Fibrillation / complications
  • Factor Xa Inhibitors / adverse effects*
  • Hemorrhage / chemically induced*
  • Humans
  • Risk Assessment
  • Risk Factors
  • Rivaroxaban / adverse effects*
  • Stroke / etiology
  • Stroke / prevention & control*

Substances

  • Factor Xa Inhibitors
  • Rivaroxaban